This protein kinase signaling pathway resembles the PI3K/AKT axis and is upregulated in breast cancer cells as a survival strategy after prolonged PI3K/AKT inhibitor treatment—and thus constitutes a mode of PI3K inhibitor resistance [59]. This evidence concerns the gene AKT1 and breast cancer.